All News Lobe Sciences Ltd.

Equities

LOBE

CA53946V2066

Market Closed - Canadian Securities Exchange Other stock markets 03:58:10 2024-06-05 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		+25.00%	0.00%

Jun. 04	Lobe Sciences Ltd. announced that it has received CAD 0.5 million in funding from Quality Chemical Laboratories, LLC, Clearway Global Llc	CI
Jun. 03	Lobe Sciences Ltd. Announces Appointment of Wesley Ramjeet to the Board of Directors	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lobe Sciences Announces Update	Jun. 04	BU
Lobe Sciences Ltd. announced that it has received CAD 0.5 million in funding from Quality Chemical Laboratories, LLC, Clearway Global Llc	Jun. 03	CI
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise	Jun. 03	BU
Lobe Sciences Ltd. Announces Appointment of Wesley Ramjeet to the Board of Directors	Jun. 03	CI
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors	May. 31	BU
Lobe Sciences Ltd. Announces Frederick D. Sancilio Ph.D. to Join Board of Directors	May. 31	CI
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors	May. 30	BU
Harry Jacobson to Join the Board of Directors of Lobe Sciences Ltd	May. 30	CI
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders	May. 21	BU
Lobe Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 29	CI
Lobe Sciences Ltd. Reports Earnings Results for the Full Year Ended August 31, 2023	Feb. 15	CI
Lobe Sciences Provides Company Review of 2023	Jan. 08	BU
Lobe Sciences Provides Update on L-130 Clinical Program	Dec. 07	MT
Lobe Sciences Provides Update on L-130 Clinical Program	Dec. 07	BU
Lobe Sciences Ltd. Provides Update on L-130 Clinical Program	Dec. 07	CI
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound	Dec. 05	MT
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound	Dec. 05	BU
Lobe Sciences : Corporate Presentation	23-10-10	PU
Lobe Sciences : Corporate Presentation Q3, 2023	23-10-09	PU
Lobe Sciences Appoints CFO	23-09-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Lobe Sciences Ltd.

Equities

LOBE

CA53946V2066

All News

Filters